{"abstract":"The National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Molecular Targeting Technologies, Inc. (MTTI); a Delaware corporation, with its principle place of business in West Chester, Pennsylvania, to practice the inventions embodied in the patent application listed in the Supplementary Information section of this notice.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2019/08/08/2019-16965.html","cfr_references":[],"citation":"84 FR 39001","comment_url":null,"comments_close_on":"2019-08-23","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NHLBI Office of Technology Transfer and Development August 23, 2019 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2019-16965","effective_on":null,"end_page":39002,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2019/08/08/2019-16965.xml","html_url":"https://www.federalregister.gov/documents/2019/08/08/2019-16965/national-institutes-of-health","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2019-16965?publication_date=2019-08-08","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2019-08-08/2019-16965/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":142,"last_updated":"2026-08-25 20:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2019-08-08/pdf/2019-16965.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2019-16965.pdf?1565181921","publication_date":"2019-08-08","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2019/08/08/2019-16965.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T23:16:01Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":39001,"subtype":null,"title":"National Institutes of Health","toc_doc":"Lutetium-177 Radiotherapeutics Against Glioblastoma Multiforme and Small-Cell Lung Carcinoma","toc_subject":"Prospective Grant of Exclusive Patent License:","topics":[],"type":"Notice","volume":84}